Staff shortfall leads to massive deficit for NHS
May 31, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The headline figure is that the NHS budget deficit for the year 2017/2018 came in at £960 million, close to …
Pfizer’s Xeljanz becomes first JAK inhibitor approved in US for active ulcerative colitis
May 31, 2018Sales and Marketing FDA, Pfizer, US, Xeljanz, pharma, ulcerative colitis
Pfizer has revealed that its Janus kinase (JAK) inhibitor Xeljanz (tofacitinib) has received FDA approval for the treatment of adult …
Allergan aims to appease investors with non-core units sell off
May 31, 2018Medical Communications Allergan, biotech, drugs, pharma, pharmaceutical
Allergan’s share price has been on a steady downward trajectory for the last year and investors are becoming increasingly frustrated …
The June 2018 issue of Pharmafocus is now live!
May 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Ebola, GDPR, Trump, UK, brexit, data managment, market access, pharma
The new June edition of Pharmafocus is now available to read online.
FDA approval for TherapeuticsMD, one year after initial rejection
May 30, 2018Sales and Marketing FDA, TherapeuticsMD, biotech, drugs, pharma, pharmaceutical
TherapeuticsMD has succeeded in changing the FDA’s mind on its Imvexxy product, after an initial rejection in May of last …
Insider Interview: Gilead’s fight against HIV comes into bloom
May 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, Insider Interview, pharma
Mike Elliott, Vice President of Medical Affairs at Gilead (pictured, right), chats about the company’s sponsorship of a ‘A life …
Google AI outperforms 58 dermatologists in detecting melanoma
May 30, 2018Research and Development AI< Google, Cancer, melanoma, pharma, skin cancer
An deep learning artificial intelligence system has demonstrated its ability to outperform over 50 human dermatologists in the detection of …
Envision Pharma Group supports Otsuka’s medical affairs activities
May 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Envision Pharma Group
Envision Pharma Group announces the successful implementation of iEnvision to connect and support Otsuka’s medical affairs activities. Otsuka Pharmaceutical Development …
AZ’s hopes for Fasenra in COPD suffer terminal blow
May 30, 2018Research and Development AstraZeneca, Fasenra, GSK, Nucala, biotech, drugs, pharma, pharmaceutical
It looked unlikely that Fasenra would achieve success in the chronic obstructive pulmonary disease (COPD) area, after it suffered in …
Allergan recalls 170,000 birth control packs in US over pregnancy fears
May 30, 2018Research and Development Allergan, FDA, Taytulla, US, birth control, pharma
Allergan has issued a voluntary recall of its birth control medication in the US marketplace after an error in packaging …
NHS England uses £10m fund to retain GPs
May 30, 2018Medical Communications, Research and Development GP, NHS, UK government, biotech, drugs, pharma, pharmaceutical
On the day that news broke, through Pulse, that over a million patients have had to move GP surgery in …
Head of Sandoz UK becomes BGMA chair
May 30, 2018Manufacturing and Production, Research and Development British Generic Manufacturers Association, biotech, drugs, pharma, pharmaceutical
Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …
One in 25 English children are severely obese by secondary school, study finds
May 29, 2018Manufacturing and Production, Research and Development England, UK, childhood obesity, obesity, pharma
A new analysis of Public Health England figures by the Local Government Association (LGA) has revealed that one in 25 …
AB Science will not seek review of masitinib rejection in Europe
May 29, 2018Manufacturing and Production, Sales and Marketing EMA, Europe, ab science, als, masitinib, pharma
AB Science has U-turned on its pursuit of a do-over on its marketing application of masitinib in Europe after the …
Roche’s Tecentriq/chemo combo smashes both co-primary endpoints at Phase 3
May 29, 2018Manufacturing and Production, Research and Development Cancer, NSCLC, Roche, immunotherapy, lung cancer, pharma, tecentriq
Roche has lifted the curtain on new Phase 3 data for its anti-PD-L1 cancer immunotherapy Tecentriq (atezolizumab), showing that the …
UCB’s Cimzia secures first-of-its-kind FDA approval in plaque psoriasis
May 29, 2018Manufacturing and Production, Sales and Marketing Cimzia, FDA, UCB, US, pharma, psoriasis
The FDA has expanded the label for UCB’s Cimzia (certolizumab pegol) in the US, approving the therapy for the treatment …
J&J terminates PD-(L)1 combo studies of cancer therapy Darzalex
May 29, 2018Manufacturing and Production, Research and Development Cancer, Genmab, J&J, JJ, Johnson & Johnson, Roche, darzalex, multiple myeloma, tecentriq
Johnson & Johnson is to terminate its studies investigating Genmab’s CD38-targeting, human IgG1κ monoclonal antibody Darzalex (daratumumab) in combination with …
Top Ten most popular articles on Pharmafile.com this week
May 25, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Gielad, Novartis, brexit, obesity, pharma, top ten
It’s a special Firday here in Europe, as today marks the advent of the General Data Protection Regulation (GDPR), an …
BioMarin receives FDA nod for its would-be blockbuster
May 25, 2018Medical Communications, Sales and Marketing BioMarin, biotech, drugs, pharma, pharmaceutical
BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …
AZ’s Imfinzi hits second major milestone at Phase 3 in unresectable lung cancer
May 25, 2018Medical Communications, Research and Development AstraZeneca, Imfinzi, NSCLC, lung cancer, pharma
AstraZeneca and its global biologics R&D MedImmune have lifted the curtain on new Phase 3 data for their immunotherapy Imfinzi …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
